ANIX Anixa Biosciences, Inc. Stock Quote

ANIX [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.49	Insider Own	4.40%	Shs Outstand	30.12M	Perf Week	6.33%
Market Cap	109.04M	Forward P/E	-	EPS next Y	-0.61	Insider Trans	4.78%	Shs Float	28.55M	Perf Month	31.72%
Income	-14.60M	PEG	-	EPS next Q	-0.13	Inst Own	11.00%	Short Float	1.77%	Perf Quarter	32.71%
Sales	-0.00M	P/S	-	EPS this Y	-0.60%	Inst Trans	-4.04%	Short Ratio	7.34	Perf Half Y	-9.49%
Book/sh	1.13	P/B	3.12	EPS next Y	-17.30%	ROA	-39.60%	Target Price	11.00	Perf Year	-12.41%
Cash/sh	1.12	P/C	3.16	EPS next 5Y	-	ROE	-40.60%	52W Range	2.30 - 5.87	Perf YTD	18.86%
Dividend	-	P/FCF	-	EPS past 5Y	4.60%	ROI	-37.10%	52W High	-39.86%	Beta	1.39
Dividend %	-	Quick Ratio	19.60	Sales past 5Y	11.30%	Gross Margin	-	52W Low	53.48%	ATR	0.30
Employees	4	Current Ratio	19.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	60.85	Volatility	10.74% 10.19%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-44.80%	Profit Margin	-	Rel Volume	1.57	Prev Close	3.29
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	68.91K	Price	3.53
Recom	2.00	SMA20	7.89%	SMA50	21.01%	SMA200	-3.12%	Volume	108,079	Change	7.46%

Apr-12-21

Initiated

H.C. Wainwright

Buy

$11

May-18-22 06:16AM	Anixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Business Simply Wall St.
May-05-22 08:30AM	Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference PR Newswire -9.34%
May-02-22 09:40AM	Has Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year? Zacks
Apr-28-22 08:30AM	Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
Apr-06-22 08:30AM	Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022 PR Newswire -5.05%
Mar-30-22 12:45PM	Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center PR Newswire
Mar-17-22 08:30AM	Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC PR Newswire +6.20%
Jan-25-22 08:30AM	Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine PR Newswire
Jan-24-22 08:30AM	Anixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor PR Newswire
Dec-16-21 08:30AM	Anixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference PR Newswire
Dec-09-21 04:38AM	Here's Why We're Not At All Concerned With Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation Simply Wall St. -8.43%
Dec-08-21 07:47AM	Anixa (ANIX) COVID Compounds Prove Effective Against Omicron Zacks +10.05%
Dec-07-21 08:30AM	Anixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant PR Newswire
Oct-26-21 08:35AM	Anixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study PR Newswire +6.81%
Oct-06-21 08:30AM	Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology PR Newswire
Oct-01-21 08:30AM	Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy PR Newswire
Sep-27-21 02:01PM	10 Best Biotech Stocks Under $10 Insider Monkey
Sep-14-21 08:31AM	Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium PR Newswire
Sep-08-21 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire
Sep-07-21 08:30AM	Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer PR Newswire
Aug-31-21 11:08AM	Anixa (ANIX) Ovarian Cancer CAR-T Drug to Enter Clinical Study Zacks
Aug-30-21 08:30AM	Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy PR Newswire
Aug-25-21 03:14PM	Anixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variant Benzinga +9.01%
08:30AM	Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant PR Newswire
Aug-23-21 08:30AM	Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative PR Newswire +6.83%
Aug-18-21 08:30AM	Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology PR Newswire +8.91%
Jun-12-21 03:12AM	Here's Why We're Not At All Concerned With Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation Simply Wall St.
May-26-21 08:30AM	Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic PR Newswire
May-20-21 08:30AM	Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application PR Newswire +5.87%
May-07-21 08:30AM	OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie PR Newswire
Apr-21-21 02:54PM	Biotech Stock Roundup: BMYs Opdivo Gets FDA Nod for Gastric Cancer & Other Updates Zacks
Apr-19-21 12:58PM	Anixa's Stock Craters As FDA Slaps Clinical Hold On CAR-T Program Benzinga -13.62%
08:30AM	Anixa Biosciences and Moffitt Cancer Center Report US FDA Request of Additional Information for CAR-T Therapy PR Newswire
Apr-14-21 09:13PM	Investing in These 2 Stocks Could Double Your Money, Say Analysts TipRanks
Apr-05-21 08:30AM	Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic PR Newswire
Mar-22-21 10:00PM	Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million PR Newswire
05:18PM	Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock PR Newswire
08:30AM	Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy PR Newswire
Mar-12-21 08:30AM	Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology PR Newswire +13.62%
Mar-08-21 08:30AM	Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference PR Newswire -9.85%
Mar-04-21 08:30AM	Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy PR Newswire -7.65%
Feb-25-21 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference PR Newswire
Feb-16-21 08:30AM	Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates PR Newswire
Jan-13-21 08:30AM	Anixa Biosciences to Present at the B. Riley Oncology Investor Conference PR Newswire
Jan-05-21 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire
Dec-21-20 08:30AM	Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine PR Newswire
Dec-14-20 09:00AM	Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical Testing PR Newswire -12.04%
Dec-11-20 08:45AM	Anixa Biosciences (ANIX) Catches Eye: Stock Jumps 8.7% Zacks
Dec-01-20 09:00AM	Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer Vaccine Technology PR Newswire +8.71%
Nov-23-20 08:30AM	Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer Vaccine PR Newswire
Oct-27-20 08:00AM	Anixa Biosciences to Host Conference Call to Provide Update on Programs PR Newswire
Oct-25-20 08:30AM	Is Anixa Biosciences (NASDAQ:ANIX) In A Good Position To Deliver On Growth Plans? Simply Wall St.
Sep-14-20 11:43AM	Insider Buys Anixa Biosciences Shares Benzinga +13.94%
Sep-08-20 08:00AM	Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference PR Newswire +6.15%
Aug-13-20 09:00AM	Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds PR Newswire
Jul-28-20 09:00AM	Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission PR Newswire
Jul-20-20 09:00AM	Anixa Biosciences Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders PR Newswire
Jul-10-20 07:25AM	The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs Benzinga +13.01%
07:00AM	Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office PR Newswire
Jul-06-20 09:00AM	Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds PR Newswire
Jul-02-20 05:00PM	Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline PR Newswire +6.71%
Jun-01-20 08:30AM	Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays PR Newswire
May-04-20 06:45AM	Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate PR Newswire +7.61%
Apr-28-20 06:32AM	Have Insiders Been Buying Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares? Simply Wall St.
Apr-23-20 07:00AM	Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek Liquid Biopsy Technology PR Newswire
Apr-21-20 06:00PM	San Jose bioscience company launches research into Covid-19 treatment American City Business Journals
Apr-20-20 06:30AM	Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics PR Newswire
Mar-23-20 06:28AM	Here's Why We're Watching Anixa Biosciences's (NASDAQ:ANIX) Cash Burn Situation Simply Wall St. -11.35%
Mar-02-20 07:00AM	Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference PR Newswire
Feb-12-20 07:00AM	Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program PR Newswire
Feb-11-20 07:16AM	Top Ranked Momentum Stocks to Buy for February 11th Zacks
Jan-06-20 07:00AM	Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference PR Newswire
Jan-02-20 05:25AM	Investors Who Bought Anixa Biosciences (NASDAQ:ANIX) Shares Three Years Ago Are Now Down 38% Simply Wall St. -8.54%
Dec-23-19 07:00AM	Anixa Biosciences to Present at Biotech Showcase 2020 PR Newswire
Dec-16-19 06:45AM	Anixa Biosciences Announces Commercial Launch of Cchek Prostate Cancer Confirmatory Test PR Newswire
Dec-13-19 05:45PM	Anixa Biosciences to Host Conference Call to Discuss Plans for 2020 PR Newswire -15.10%
06:45AM	Anixa Biosciences Provides Update on CAR-T Program PR Newswire
Dec-02-19 07:00AM	Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium PR Newswire
Nov-26-19 07:00AM	Anixa Biosciences Announces Genesis Research to Join Cchek Prostate Cancer Study PR Newswire +7.29%
Nov-22-19 07:00AM	Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek Prostate Cancer Study PR Newswire
Nov-20-19 07:00AM	Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek Prostate Cancer Study PR Newswire
Nov-07-19 07:00AM	Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer PR Newswire
Nov-05-19 07:00AM	Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine PR Newswire
Nov-03-19 07:38AM	What Kind Of Shareholders Own Anixa Biosciences, Inc. (NASDAQ:ANIX)? Simply Wall St.
Oct-28-19 07:00AM	Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board PR Newswire
Oct-25-19 07:00AM	Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek Prostate Cancer Study PR Newswire
Oct-22-19 07:00AM	Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019) PR Newswire
Oct-15-19 07:00AM	Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts PR Newswire +5.11%
Oct-10-19 07:00AM	Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board PR Newswire
Sep-23-19 07:00AM	Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek Prostate Cancer Study PR Newswire
Sep-19-19 07:53AM	Should You Worry About Anixa Biosciences, Inc.'s (NASDAQ:ANIX) Cash Runway? Simply Wall St.
07:00AM	Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek Prostate Cancer Study PR Newswire
Sep-16-19 07:00AM	Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree PR Newswire
Aug-26-19 07:00AM	Anixa Biosciences to Present at Two Upcoming Investor Conferences PR Newswire
Jul-29-19 07:00AM	Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek Prostate Cancer Study PR Newswire
Jul-24-19 07:00AM	Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology PR Newswire
Jul-23-19 01:22PM	Have Insiders Been Buying Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares? Simply Wall St.
Jul-22-19 07:00AM	Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek Prostate Cancer Study PR Newswire
Jul-17-19 12:25PM	Anixa Bioscience's Deal With Cleveland Clinic Sends Shares Higher Benzinga
07:00AM	Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology PR Newswire

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Titterton Lewis H jr	Director	Apr 26	Buy	2.79	10,000	27,900	988,070	Apr 27 10:01 AM
Catelani Michael	President	Apr 21	Buy	2.66	5,500	14,630	18,135	Apr 22 09:50 AM
Catelani Michael	President	Apr 20	Buy	2.53	2,509	6,348	12,635	Apr 21 11:28 AM
Titterton Lewis H jr	Director	Jan 12	Buy	3.28	5,000	16,400	978,070	Jan 13 10:23 AM
Titterton Lewis H jr	Director	Jan 11	Buy	3.20	2,000	6,400	973,070	Jan 12 09:54 AM
Titterton Lewis H jr	Director	Jan 10	Buy	3.08	6,000	18,480	971,070	Jan 11 09:21 AM
Titterton Lewis H jr	Director	Jan 07	Buy	3.08	11,000	33,880	965,070	Jan 10 09:36 AM
KUMAR AMIT	Chief Executive Officer	Jan 07	Buy	3.00	20,000	60,000	314,000	Jan 07 10:32 AM
Titterton Lewis H jr	Director	Oct 29	Buy	4.76	18,244	86,841	954,070	Nov 01 01:32 PM
KUMAR AMIT	Chief Executive Officer	Oct 29	Buy	4.77	2,000	9,540	294,000	Nov 01 11:05 AM
Titterton Lewis H jr	Director	Jul 26	Buy	4.21	30,000	126,300	935,826	Jul 28 09:00 AM
KUMAR AMIT	Chief Executive Officer	Jul 23	Buy	4.28	5,000	21,400	292,000	Jul 27 01:08 PM
Baskies Arnold M	Director	Jul 23	Buy	4.33	19,000	82,270	100,000	Jul 27 09:56 AM
KUMAR AMIT	Chief Executive Officer	Jul 16	Buy	3.94	10,000	39,400	287,000	Jul 20 09:00 AM
Titterton Lewis H jr	Director	Jul 16	Buy	4.07	10,000	40,700	905,826	Jul 19 12:39 PM
Baskies Arnold M	Director	Jul 15	Buy	3.90	20,000	78,000	81,000	Jul 16 11:22 AM
Titterton Lewis H jr	Director	Jul 15	Buy	3.65	2,200	8,030	895,826	Jul 19 12:39 PM
Gottschalk Emily	Director	Jul 15	Buy	3.96	20,065	79,457	45,665	Jul 16 12:45 PM
Titterton Lewis H jr	Director	Jul 14	Buy	3.72	23,300	86,676	893,626	Jul 15 11:19 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience